(11-369) A real-world comparative analysis of maximum-dose semaglutide versus tirzepatide on weight reduction and metabolic outcomes in overweight and obese individuals
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: Mount Sinai Health System Residency Program Type: PGY2 (Ambulatory Care Pharmacy) Residency Program Location: New York
